Notes
Oxid a tive Clea va ge of Cya n ok etop h osp h or a n e 1 to
J . Org. Chem., Vol. 66, No. 10, 2001 3609
2.0 Hz, 1H), 7.11 (dd, J ) 8.4, 2.0 Hz, 1H), 6.82 (d, J ) 8.4 Hz,
1H), 3.87 (s, 3H), 3.86 (s, 3H), 3.15 (t, J ) 7.4 Hz, 2H), 2.88 (t,
J ) 7.4 Hz, 2H); 13C NMR (75.47 MHz, CDCl3) δ 192.94, 161.14,
154.45, 133.62, 133.15, 128.44, 111.99, 111.57, 56.28, 53.05,
40.95, 27.66; IR (CH2Cl2) 1734 cm-1; EIMS (20 eV) m/z 302 (M+,
47), 300 (M+, 48), 284 (12), 282 (12), 243 (23), 241 (26), 201 (95),
199 (100); HRMS (EI) for C12H13O4Br (M+), calcd 299.9997, found
299.9985.
Meth yl 4-Ben zo[1,3]d ioxol-5-yl-2-oxobu tyr a te (7a ). Ana-
lytical TLC (silica gel 60), 50% EtOAc in n-hexane, Rf ) 0.56;
as a white solid; mp 51-53 °C; 1H NMR (300 MHz, CDCl3) δ
6.63-6.74 (m, 3H), 5.92 (s, 2H), 3.86 (s, 3H), 3.14 (t, J ) 7.4 Hz,
2H), 2.88 (t, J ) 7.4 Hz, 2H); 13C NMR (67.94 MHz, CDCl3) δ
193.15, 161.23, 147.71, 146.05, 133.78, 121.20, 108.87, 108.30,
100.89, 53.01, 41.26, 28.70; IR (CH2Cl2) 1732 cm-1; EIMS (20
eV) m/z 236 (M+, 30), 177 (13), 135 (100); HRMS (EI) for
C12H12O5 (M+), calcd 236.0685, found 236.0682.
Meth yl 2-Oxoh ep t-3-en oa te (8a ). Analytical TLC (silica gel
60), 20% EtOAc in n-hexane, Rf ) 0.5; as a syrup; 1H NMR (270
MHz, CDCl3) δ 7.21 (dt, J ) 16.0, 7.0 Hz, 1H), 6.66 (dt, J )
16.0, 2.0 Hz, 1H), 3.89 (s, 3H), 2.30 (ddd, J ) 14.5, 7.5, 2.0 Hz,
2H), 1.55 (sextet, J ) 7.5 Hz, 2H), 0.96 (t, J ) 7.5 Hz, 3H); 13C
NMR (67.94 MHz, CDCl3) δ 183.01, 162.78, 155.21, 125.20,
52.87, 35.10, 21.06, 13.71; IR (CH2Cl2) 1737 cm-1; EIMS (20 eV)
m/z 156 (M+, 1), 113 (13); HRMS (EI) for C8H12O3 (M+), calcd
156.0786, found 156.0765.
r-Keto Am id e 14a (Ta ble 1, en tr y 14). A solution of L-leucine
methyl ester in CH2Cl2 was prepared by treating L-leucine
methyl ester hydrochloride salt (44 mg, 0.24 mmol), K2CO3 (0.1
g, 0.72 mmol), and two drops of H2O in CH2Cl2 (2 mL). After
stirring for 10 min, the solution was dried over anhydrous Na2-
SO4, filtered, and used for the next step. To a solution of 1 (0.10
g, 0.24 mmol) in CH2Cl2 (5 mL) was added a solution of
dimethyldioxirane in acetone (0.04 M, 12 mL, 0.48 mmol) at -78
°C. After stirring for 5 min, TLC analysis indicated the disap-
pearance of starting materials. The solution of L-leucine methyl
ester in CH2Cl2 was added to the reaction mixture. After stirring
for 10 min, the solvents were evaporated off under reduced
pressure. The crude residue was subjected to flash column
chromatography (20% EtOAc in n-hexane) to provide 14a (0.049
g, 72% yield) as a colorless oil. Analytical TLC (silica gel 60),
50% EtOAc in n-hexane, Rf ) 0.71; [R]20D ) -10.7° (c 0.42, CH2-
Cl2); 1H NMR (500 MHz, CDCl3) δ 7.27 (d, J ) 6.4 Hz, 1H), 4.56-
4.60 (m, 1H), 3.75 (s, 3H), 2.90 (t, J ) 7.0 Hz, 2H), 1.68-1.74
(m, 1H), 1.58-1.66 (m, 3H), 1.29-1.34 (m, 7H), 0.95 (d, J ) 6.2
Hz, 6H), 0.88 (t, J ) 6.8 Hz, 3H); 13C NMR (125.76 MHz, CDCl3)
δ 198.58, 172.39, 159.83, 52.48, 50.72, 41.42, 36.77, 31.51, 28.72,
24.86, 23.14, 22.77, 22.46, 21.79, 14.01; IR (CH2Cl2) 3401, 1745,
1689 cm-1; EIMS (20 eV) m/z 285 (M+, 3), 229 (26), 172 (22),
144 (100); HRMS (EI) for C15H27NO4 (M+), calcd 285.1940, found
285.1923.
Meth yl 4-ter t-Bu toxy-2-oxoh ep ta n oa te (2a ). Analytical
TLC (silica gel 60), 50% EtOAc in n-hexane, Rf ) 0.5; as a syrup;
1H NMR (300 MHz, CDCl3) δ 4.03 (quintet, J ) 5.9 Hz, 1H),
3.87 (s, 3H), 3.00 (dd, J ) 15.4, 6.4 Hz, 1H), 2.95 (dd, J ) 15.3,
5.6 Hz, 1H), 1.29-1.51 (m, 4H), 1.16 (s, 9H), 0.91 (t, J ) 7.3 Hz,
3H); 13C NMR (75.48 MHz, CDCl3) δ 193.72, 161.71, 73.98, 67.89,
52.81, 46.14, 39.28, 28.31, 18.60, 14.07; IR (KBr) 1731 cm-1; MS
(ESI) m/z 231 (M+ + 1, 10), 157 (16); HRMS (EI) for C8H13O3
(M+ - t-BuO), calcd 157.0865, found 157.0865.
Meth yl 6-(3,3-Dim eth yl-oxir a n -2-yl)-4-m eth yl-2-oxoh ex-
a n oa te (9a ). Analytical TLC (silica gel 60), 50% EtOAc in
n-hexane, Rf ) 0.66; as a syrup; H NMR (300 MHz, CDCl3) δ
1
3.87 (s, 3H), 2.86 (ddd, J ) 17.0, 6.0, 3.5 Hz, 1H), 2.66-2.74 (m,
2H), 2.12 (septet, J ) 6.6 Hz, 1H), 1.34-1.63 (m, 4H), 1.31 (s,
3H), 1.27 (d, J ) 2.0 Hz, 3H), 0.97 (d, J ) 7.0 Hz, 3H); 13C NMR
(75.47 MHz, CDCl3) δ 193.82, 161.62, 64.20, 64.16, 58.35, 58.23,
52.95, 46.26, 46.20, 33.35, 28.61, 28.59, 26.37, 26.34, 24.86, 19.63,
19.60, 18.70, 18.65; IR (KBr) 1731 cm-1; EIMS (20 eV) m/z 228
(M+, 1), 211 (13), 169 (26), 123 (100); HRMS (EI) for C12H20O4
(M+), calcd 228.1362, found 228.1357.
Meth yl 5-Hyd r oxy-2-oxoh ep t-3-en oa te (10a ). Analytical
TLC (silica gel 60), 50% EtOAc in n-hexane, Rf ) 0.8; as a syrup;
1H NMR (500 MHz, CDCl3) δ 7.18 (dd, J ) 16.0, 4.5 Hz, 1H),
6.91 (dd, J ) 16.0, 2.0 Hz, 1H), 4.35-4.39 (m, 1H), 3.90 (s, 3H),
1.61-1.74 (m, 2H), 0.10 (t, J ) 7.5 Hz, 3H); 13C NMR (125.78
MHz, CDCl3) δ 182.87, 162.37, 154.94, 123.04, 72.50, 52.96,
29.44, 9.47; IR (KBr) 3473, 1737 cm-1; EIMS (20 eV) m/z 113
(M+ - COOMe, 100); HRMS (EI) for C6H9O2 (M+ - COOMe),
calcd 113.0602, found 113.0589.
Met h yl 4-ter t-Bu t yld im et h ylsilyloxy-2-oxoh ep t a n oa t e
(3a ). Analytical TLC (silica gel 60), 30% EtOAc in n-hexane, Rf
) 0.6; as a syrup; 1H NMR (300 MHz, CDCl3) δ 4.18 (quintet, J
) 5.5 Hz, 1H), 3.80 (s, 3H), 2.97 (dd, J ) 15.5, 7.1 Hz, 1H), 2.85
(dd, J ) 15.5, 5.1 Hz, 1H), 1.20-1.47 (m, 4H), 0.96 (t, J ) 7.0
Hz, 3H), 0.82 (s, 9H), 0.05 (s, 3H), 0.01 (s, 3H); 13C NMR (67.94
MHz, CDCl3) δ 193.18, 161.43, 68.65, 52.93, 46.44, 39.97, 25.75,
18.20, 17.95, 14.12, -4.52, -4.86; IR (KBr) 1732 cm-1; CIMS
m/z 289 (M+ + 1, 17), 231 (8), 201 (26), 187 (100), 159 (53); HRMS
(EI) for C10H19O4Si (M+ - t-Bu), calcd 231.1053, found 231.1058.
Meth yl 4-Acetoxy-2-oxoh ep ta n oa te (4a ). Analytical TLC
(silica gel 60), 50% EtOAc in n-hexane, Rf ) 0.5; as a syrup; 1H
NMR (300 MHz, CDCl3) δ 5.20-5.30 (m, 1H), 3.88 (s, 3H), 3.11
(dd, J ) 16.3, 4.3 Hz, 1H), 2.98 (dd, J ) 16.3, 8.0 Hz, 1H), 2.01
(s, 3H), 1.24-1.69 (m, 4H), 0.94 (t, J ) 7.4 Hz, 3H); 13C NMR
(125.76 MHz, CDCl3) δ 190.80, 170.88, 160.96, 69.93, 53.12,
44.16, 36.35, 20.96, 18.43, 13.75; IR (CH2Cl2) 1735 cm-1; CIMS
Meth yl 2-Oxon on a d ec-10-yn oa te (11a ). Analytical TLC
(silica gel 60), 30% EtOAc in n-hexane, Rf ) 0.6; as a syrup; 1H
NMR (300 MHz, CDCl3) 3.87 (s, 3H), 2.84 (t, J ) 7.2 Hz, 2H),
2.11-2.16 (m, 4H), 1.27-1.61 (m, 22H), 0.86-0.89 (m, 3H); 13
C
NMR (75.48 MHz, CDCl3) δ 194.24, 161.55, 80.32, 79.98, 52.83,
39.24, 31.81, 29.19, 29.12, 29.09, 28.99, 28.84, 28.79, 28.77, 28.53,
22.85, 22.62, 18.71, 18.66, 14.06; IR (CH2Cl2) 1733 cm-1; EIMS
(20 eV) m/z 322 (M+, 7), 263 (26); HRMS (EI) for C20H34O3 (M+),
calcd 322.2508, found 322.2512.
m/z 217 (M+ + 1, 12), 129 (18); HRMS (EI) for C7H13O2 (M+
COCOOMe), calcd 129.0916, found 129.0927.
-
Meth yl 4-Hyd r oxy-6-p r op yl-[1,3]d ioxa n e-4-ca r boxyla te
(5a ). Analytical TLC (silica gel 60), 30% EtOAc in n-hexane, Rf
12a .3a Analytical TLC (silica gel 60), 50% EtOAc in n-hexane,
) 0.23; as a syrup; H NMR (300 MHz, CDCl3) δ 5.27 (d, J ) 6
Rf ) 0.36; as a syrup; [R]20 ) +24.5° (c 0.92 CH2Cl2); 1H NMR
1
D
Hz, 1H), 4.89 (d, J ) 6 Hz, 1H), 3.86-3.96 (m, 1H), 3.85 (s, 3H),
3.82 (br s, 1H), 2.12 (t, J ) 12 Hz, 2H), 1.26-1.64 (m, 5H), 0.93
(t, J ) 7.1 Hz, 3H); 13C NMR (75.48, CDCl3) δ 170.11, 93.27,
87.40, 71.91, 53.33, 37.74, 36.45, 17.95, 13.91; IR (CH2Cl2) 3501,
1763 cm-1; EIMS (20 eV) m/z 204 (M+, 6); HRMS (EI) for
C9H16O5 (M+), calcd 204.0998, found 204.0986.
3-Hyd r oxy-5-p r op yl-5H-fu r a n -2-on e (5b). Analytical TLC
(silica gel 60), 50% EtOAc in n-hexane, Rf ) 0.3; as a syrup; 1H
NMR (300 MHz, CDCl3) δ 6.47 (br s, 1H), 6.22 (d, J ) 1.9 Hz,
1H), 4.96 (m 1H), 1.30-1.80 (m, 4H), 0.97 (t, J ) 7.3 Hz, 3H);
13C NMR (75.48 MHz, CDCl3) δ 170.36, 142.03, 119.06, 79.57,
36.20, 18.22, 13.81; IR (CH2Cl2) 3502, 1763 cm-1; EIMS (20 eV)
m/z 142 (M+, 11), 125 (16); HRMS (EI) for C7H10O3 (M+), calcd
142.0630, found 142.0639.
(300 MHz, CDCl3) δ 7.27-7.31 (m, 5H), 5.12-5.20 (m, 1H), 5.02-
5.08 (m, 1H), 3.85 (s, 3H), 3.01-3.24 (m, 2H), 1.40 (s, 9H); 13C
NMR (75.48 MHz, CDCl3) δ 192.07, 160.63, 154.78, 135.01,
129.14, 128.50, 127.02, 80.25, 57.71, 53.00, 37.09, 28.15; IR (CH2-
Cl2) 3430, 1756, 1720 cm-1; MS (ESI) m/z 307 (M+, 7); HRMS
(EI) for C13H18NO2 (M+ - COCOOMe), calcd 220.1337, found
220.1331.
Ack n ow led gm en t. This work was supported by The
University of Hong Kong (URC/CRCG grant), Hong
Kong Research Grants Council, and HKU Generic Drug
Research Program.
Su p p or tin g In for m a tion Ava ila ble: Experimental de-
tails for preparation of cyanoketophosphoranes 1-12; 1H and
13C NMR spectra of new compounds. This material is available
Met h yl 4-(3-Br om o-4-m et h oxyp h en yl)-2-oxob u t yr a t e
(6a ).16 Analytical TLC (silica gel 60), 30% EtOAc in n-hexane,
Rf ) 0.36; as a syrup; 1H NMR (300 MHz, CDCl3) δ 7.39 (d, J )
(16) Yang, D.; Wong, M.-K.; Yan, Z. J . Org. Chem. 2000, 65, 4179.
J O0015974